Table 2.
Brain metastasis | Primary breast cancer | Total | |
---|---|---|---|
− | + | ||
ER status | |||
− | 10 (47.6%) | 1 (4.8%) | 11 (52.4%) |
+ | 1 (4.8%) | 9 (42.9%) | 10 (47.6%) |
PR status | |||
− | 10 (47.6%) | 2 (9.5%) | 12 (57.1%) |
+ | 6 (28.6%) | 3 (14.3%) | 9 (42.9%) |
HER2 status | |||
− | 10 (47.6%) | 3 (14.3%) | 13 (61.9%) |
+ | 2 (9.5%) | 6 (28.6%) | 8 (38.1%) |
ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2